Green Cross likely to supply 12 million doses of flu A vaccines

Published: 2009-07-23 06:58:00

Updated: 2009-07-23 06:58:00

Although health authorities downplay the worries about the H1N1 flu, stressing that the virus presently remains in a mild form, the continuing spread of influenza A, still in the early stages of the outbreak, has critics concerned about the country's readiness to combat a possible epidemic.

Ko...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK